Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > More proof on extended duration of PMX-DHP !
View:
Post by mercedesman on Apr 30, 2021 9:47am

More proof on extended duration of PMX-DHP !

https://read.qxmd.com/read/33910191/impact-of-extended-duration-of-polymyxin-b-immobilized-fiber-column-direct-hemoperfusion-on-hemodynamics-vasoactive-substance-requirement-and-pulmonary-oxygenation-in-patients-with-sepsis-an-observational-study


"DISCUSSION/CONCLUSIONS: Longer duration of PMX-DHP was associated with the improved MAP and decreased volume of vasoactive-inotropic agents compared with the conventional duration. Eight and longer hours duration of PMX-DHP was associated with the improvement in the pulmonary oxygenation. Further studies are needed to confirm the efficacy of longer duration of PMX-DHP in patients with septic shock."

Three points:

Who knew that by removing more endotoxins (perhaps until the infection sourse has been adequantely controlled) would improve outcomes?

Wonder how the FDA will deal with this complelling new real world evidence as they finalize their reiew of Tigris results?

Would using more filters or higher capacity filters increase the long term revenues of Spectral assuming FDA approva?  Hmmmm?!

MM
Comment by inspecthrgadget on Apr 30, 2021 10:05am
I am expecting a similar result from the ongoing Covid study in the US. There, it the potential of additional filter use that could expand on the "dose response" relationship that Spilker et al recognized in the phase 3 trial. We are ALL learning as we proceed, perhsps more important was the recognition of the PMX filters capacity, perhaps the trial's biggest learn as wr do have a ...more  
Comment by Domino55 on Apr 30, 2021 10:08am
MM- this BB has how many regular posters? 3, 4 maybe. it just occurred to me that they have more North American regulatory approvals than they do people posting and discussing them on Stockhouse. how many micro caps can say that?!
Comment by mercedesman on Apr 30, 2021 10:30am
lol.  Quite right Although it may be more correct to say 3 - 4 vocal posters, or posters of value. typical number of reads range between 70 and 200, depending on the topic. Would be nice to hear from a few of silent majority, once in a while. If they are all  weak incarnations of  a few bad guys, I'm not sure why St and his various alias' would go to the trouble of  ...more  
Comment by mercedesman on Apr 30, 2021 11:04am
Wow !!!!???!!! That seems like very good news doesn't  it MM?  (resist the temptation Davi - lately you're coming around lol) If you place the following key puzzle peices, doesn't it make you feel better about your investment, despite Mgt's silence and or modest behaviour? Kellum takes a two year leave from UoP to become CMO of Spectral Kellum acquires a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities